These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27855451)

  • 1. [Triple fix-dose combination for treatment of COPD: convenient and effective].
    Worth H; Criée CP
    Dtsch Med Wochenschr; 2016 Nov; 141(23):1668. PubMed ID: 27855451
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple inhalers for obstructive airways disease: will they be useful?
    Barnes PJ
    Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
    [No Abstract]   [Full Text] [Related]  

  • 3. [Asthma and COPD: guidance in the jungle of inhalative drugs].
    Hering T
    MMW Fortschr Med; 2015 May; 157(10):59, 61-2. PubMed ID: 26019099
    [No Abstract]   [Full Text] [Related]  

  • 4. Seebri Neohaler and Utibron Neohaler for COPD.
    Med Lett Drugs Ther; 2016 Mar; 58(1491):39-41. PubMed ID: 27027687
    [No Abstract]   [Full Text] [Related]  

  • 5. POINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV
    Chalmers JD
    Chest; 2018 Apr; 153(4):778-782. PubMed ID: 29474807
    [No Abstract]   [Full Text] [Related]  

  • 6. COUNTERPOINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV
    Pavord ID
    Chest; 2018 Apr; 153(4):782-784. PubMed ID: 29410364
    [No Abstract]   [Full Text] [Related]  

  • 7. When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals.
    Gaduzo S; McGovern V; Roberts J; Scullion JE; Singh D
    Int J Chron Obstruct Pulmon Dis; 2019; 14():391-401. PubMed ID: 30863039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple therapy for COPD: a crude analysis from a systematic review of the evidence.
    Lopez-Campos JL; Carrasco-Hernandez L; Quintana-Gallego E; Calero-Acuña C; Márquez-Martín E; Ortega-Ruiz F; Soriano JB
    Ther Adv Respir Dis; 2019; 13():1753466619885522. PubMed ID: 31694491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC; Hurst MM
    Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Too many options, too little choice in COPD?
    Drug Ther Bull; 2016 Feb; 54(2):13. PubMed ID: 26848017
    [No Abstract]   [Full Text] [Related]  

  • 11. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical burden of illness among patients with severe eosinophilic COPD.
    Müllerová H; Meeraus WH; Galkin DV; Albers FC; Landis SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():741-755. PubMed ID: 31114180
    [No Abstract]   [Full Text] [Related]  

  • 13. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycopyrrolate/formoterol (Bevespi Aerosphere) for COPD.
    Med Lett Drugs Ther; 2016 Oct; 58(1505):130-132. PubMed ID: 27701364
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of inhaled corticosteroids/long-acting beta-2 agonist fix combinations in COPD].
    Demir T; Günen H; Polatlı M; Yıldırım N
    Tuberk Toraks; 2011; 59(1):89-100. PubMed ID: 21554238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological management--inhaled treatment.
    Currie GP; Lipworth BJ
    BMJ; 2006 Jun; 332(7555):1439-41. PubMed ID: 16777889
    [No Abstract]   [Full Text] [Related]  

  • 17. POINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? Yes.
    Cazzola M; Matera MG
    Chest; 2018 Oct; 154(4):746-748. PubMed ID: 30290925
    [No Abstract]   [Full Text] [Related]  

  • 18. Three-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysis.
    Penning-van Beest F; van Herk-Sukel M; Gale R; Lammers JW; Herings R
    Respir Med; 2011 Feb; 105(2):259-65. PubMed ID: 20705441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Novel drugs for COPD treatment].
    Gillissen A
    Pneumologie; 2014 Sep; 68(9):594-8. PubMed ID: 25003907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.